These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 23772644

  • 1. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
    Panagiotidis E, Quigley AM, Pencharz D, Ardeshna K, Syed R, Sajjan R, Bomanji J.
    Leuk Lymphoma; 2014 Mar; 55(3):515-9. PubMed ID: 23772644
    [Abstract] [Full Text] [Related]

  • 2. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
    Gheysens O, Thielemans S, Morscio J, Boeckx N, Goffin KE, Deroose CM, Sagaert X, Wlodarska I, Verhoef G, Dierickx D, Tousseyn T.
    Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
    [Abstract] [Full Text] [Related]

  • 3. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Takehana CS, Twist CJ, Mosci C, Quon A, Mittra E, Iagaru A.
    Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
    [Abstract] [Full Text] [Related]

  • 4. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Vali R, Punnett A, Bajno L, Moineddin R, Shammas A.
    Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders.
    Montes de Jesus FM, Glaudemans AWJM, Tissing WJ, Dierckx RAJO, Rosati S, Diepstra A, Noordzij W, Kwee TC.
    J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
    [Abstract] [Full Text] [Related]

  • 6. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
    Zimmermann H, Denecke T, Dreyling MH, Franzius C, Reinke P, Subklewe M, Amthauer H, Kneba M, Riess H, Trappe RU.
    Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
    [Abstract] [Full Text] [Related]

  • 7. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
    Yang J, Zhuang H.
    Hell J Nucl Med; 2015 May; 18(2):136-9. PubMed ID: 26187213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic performances of F-18 FDG PET or PET/CT for detection of post-transplant lymphoproliferative disorder: a systematic review and meta-analysis.
    Kim DH, Kim SJ.
    Nucl Med Commun; 2020 Jun; 41(6):533-539. PubMed ID: 32282633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The value of 18 F-FDG PET/CT quantitative indexes in the diagnosis of nondestructive posttransplant lymphoproliferative disorders after pediatric liver transplantation.
    Si Z, Lu D, Zhai L, Zheng W, Dong C, Sun C, Wang K, Zhang W, Wei X, Zhang Z, Zhao S, Gao W, Shen Z.
    Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
    [Abstract] [Full Text] [Related]

  • 15. Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
    Yoon GY, Kim MY, Huh JR, Jo KW, Shim TS.
    Medicine (Baltimore); 2015 Aug; 94(31):e1274. PubMed ID: 26252295
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 18. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
    von Falck C, Maecker B, Schirg E, Boerner AR, Knapp WH, Klein C, Galanski M.
    Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Importance of Bone Marrow Uptake on Baseline 18F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma.
    Soydal C, Koksoy EB, Yasar A, Turgal E, Erdogan BD, Akbulut H, Kucuk NO.
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [Abstract] [Full Text] [Related]

  • 20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.